Weill Cornell Medicine-Qatar (WCM-Q) scientists have launched a groundbreaking online tool called Connecting Omics (COmics) to advance the study of human physiology at the molecular level. This innovative tool integrates data from thousands of molecules, offering unparalleled insights into disease mechanisms and molecular processes.
Developed over 12 years of research, the COmics tool incorporates a vast dataset derived from blood, urine, and saliva samples of 391 participants in the multiethnic Qatar Metabolomics Study of Diabetes (QMDiab). The study, conducted in collaboration with Hamad Medical Corporation, generated 6,300 individual molecular data points analyzed across 18 platforms.
The COmics tool combines genomic, transcriptomic, proteomic, and metabolomic data to provide researchers with an integrative view of molecular interactions. This enables the exploration of genetic traits, DNA methylation, and gene expression linked to specific proteins, metabolic pathways, and diseases.
Karsten Suhre, senior author and professor of physiology and biophysics at WCM-Q, highlighted the purpose of the initiative:
“Our idea was to bring together everything we have learned over more than a decade of multiomics research to create a comprehensive molecular model of the human body and its processes.”
The Molecular Human map, available online, provides a user-friendly, interactive platform for researchers to investigate the complex interrelationships between molecular traits and observable phenotypes. Dr. Anna Halama, assistant professor of research in physiology and biophysics, emphasized the tool’s utility:
“Our integrative omics approach provides an overview of the interrelationships between different molecular traits and their association with a person’s phenotype – their observable traits, such as their physical appearance, biochemical processes, and behaviors.”
This innovative resource has transformative potential, enabling scientists to unlock new discoveries in disease mechanisms and molecular biology, paving the way for future medical breakthroughs.
